Literature DB >> 889223

Natural history of sudden sensorineural hearing loss.

D E Mattox, F B Simmons.   

Abstract

This is a prospective in-depth study of patients with sudden idiopathic sensorineural hearing loss. We found that 65% recover completely to functional hearing levels spontaneously and independent of any type of medical treatment. The majority do so within 14 days and many within the first few days. Prognosis can be predicted according to the slope of the initial audiogram (low-frequency losses do better than high-frequency losses), hearing at 8 kHz, erythrocyte sedimentation rates, in some select instances spatial disorientation symptoms, and speech discrimination scores. There was a very poor correlation between hearing and vestibular test abnormalities, except hypoactive calories. There were no correlations with age (excepting the very elderly), with antecedent respiratory infections, hypertension, diabetes, or other chronic diseases. We conclude that there is a fundamental difference in the behavior of apical and basal cochlea losses, that hearing recovery is always better at low than at high frequencies, that because of the high spontaneous recovery rates, tympanotomies seeking peri-lymph fistulas should be delayed ten days unless there is a progressive hearing loss, and that none of the current recommended treatments, especially histamine, have any effect on the outcome.

Entities:  

Mesh:

Year:  1977        PMID: 889223     DOI: 10.1177/000348947708600406

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  138 in total

1.  Early combination treatment with intratympanic steroid injection in severe to profound sudden sensorineural hearing loss improves speech discrimination performance.

Authors:  Young Ho Kim; Kyung Tae Park; Byung Yoon Choi; Min Hyun Park; Jun Ho Lee; Seung-Ha Oh; Sun O Chang
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-08       Impact factor: 2.503

2.  Therapy of hearing disorders - conservative procedures.

Authors:  Stefan Plontke
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2005-09-28

3.  Intratympanic dexamethasone perfusion versus injection for treatment of refractory sudden sensorineural hearing loss.

Authors:  Lihua Li; Jihao Ren; Tuanfang Yin; Wei Liu
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-06       Impact factor: 2.503

Review 4.  [Possible molecular mechanisms of spontaneous remission in sudden idiopathic hearing loss].

Authors:  U-R Heinrich; J Brieger; R H Stauber; W J Mann
Journal:  HNO       Date:  2011-11       Impact factor: 1.284

5.  Current concepts in the diagnosis and treatment of sudden sensorineural hearing loss.

Authors:  J M Schweinfurth; S M Parnes; M Very
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

6.  In vivo imaging of mammalian cochlear blood flow using fluorescence microendoscopy.

Authors:  Ashkan Monfared; Nikolas H Blevins; Eunice L M Cheung; Juergen C Jung; Gerald Popelka; Mark J Schnitzer
Journal:  Otol Neurotol       Date:  2006-02       Impact factor: 2.311

Review 7.  Sudden deafness: is it viral?

Authors:  Saumil N Merchant; Marlene L Durand; Joe C Adams
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2008-02-01       Impact factor: 1.538

8.  How long should the sudden hearing loss patients be followed after early steroid combination therapy?

Authors:  In Seok Moon; Jin Kim; So-Yoon Lee; Hyun Seung Choi; Won-Sang Lee
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-13       Impact factor: 2.503

Review 9.  Intratympanic steroids as primary initial treatment of idiopathic sudden sensorineural hearing loss. The Hospital Universitario Ramón y Cajal experience and review of the literature.

Authors:  Tomás Labatut; María José Daza; Antonio Alonso
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-20       Impact factor: 2.503

10.  Combined treatment of sudden sensorineural hearing loss with steroid, dextran and piracetam: experience with 68 cases.

Authors:  Erdal Samim; Rahmi Kilic; Ali Ozdek; Hakan Gocmen; Adil Eryilmaz; Ilhan Unlu
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-08-22       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.